We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reevaluation Of Systemic Early Neuromuscular Blockade (ROSE)

This study is currently recruiting participants.
Verified May 2017 by David Alan Schoenfeld, Massachusetts General Hospital
Sponsor:
ClinicalTrials.gov Identifier:
NCT02509078
First Posted: July 27, 2015
Last Update Posted: May 25, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
David Alan Schoenfeld, Massachusetts General Hospital